<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03510910</url>
  </required_header>
  <id_info>
    <org_study_id>18-00167</org_study_id>
    <nct_id>NCT03510910</nct_id>
  </id_info>
  <brief_title>Multimodal Analgesia With Acetaminophen vs. Narcotics Alone After Hip Arthroscopy</brief_title>
  <official_title>Multimodal Analgesia With Acetaminophen vs. Narcotics Alone After Hip Arthroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this proposed study is to evaluate the efficacy of a multimodal approach to&#xD;
      analgesia for patient's pain after hip arthroscopy and to also assess if this new approach&#xD;
      will result in a reduction in post-operative narcotic use.&#xD;
&#xD;
      This study is a single-center, randomized prospective study comparing post-operative pain&#xD;
      scores and narcotic consumption between individuals receiving acetaminophen along with a&#xD;
      reduced quantity of Percocet (to be used as needed for breakthrough pain) and individuals&#xD;
      receiving Percocet only. Both pain management options are considered to be standard of care.&#xD;
      Both cohorts will receive aspirin for DVT prophylaxis and celecoxib for heterotopic&#xD;
      ossification prophylaxis.&#xD;
&#xD;
      The primary objective of the study are to compare patients' narcotic consumption and reported&#xD;
      pain following arthroscopic hip surgery, and determine if acetaminophen can provide adequate&#xD;
      pain relief compared to a narcotic medication.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 10, 2018</start_date>
  <completion_date type="Actual">December 1, 2019</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>7 days post-surgery</time_frame>
    <description>Satisfaction was reported on a Likert-type scale of 1-10 (the higher the score, the higher the satisfaction)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Morphine-equivalent Consumption</measure>
    <time_frame>7 days post-surgery</time_frame>
    <description>Amount of oxycodone/acetaminophen (Percocet) in 5mg/325mg doses will be recorded in number of pills</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Score on Visual Analog Scale (VAS) of Pain</measure>
    <time_frame>24 hours post-surgery</time_frame>
    <description>Pain severity scores at rest will be assessed by use of VAS. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain.&quot; The higher the score, the worse the pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Score on Visual Analog Scale (VAS) of Pain</measure>
    <time_frame>4 days post-surgery</time_frame>
    <description>Pain severity scores at rest will be assessed by use of VAS. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain.&quot; The higher the score, the worse the pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Score on Visual Analog Scale (VAS) of Pain</measure>
    <time_frame>7 days post-surgery</time_frame>
    <description>Pain severity scores at rest will be assessed by use of VAS. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain.&quot; The higher the score, the worse the pain.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Hip Arthroscopy</condition>
  <arm_group>
    <arm_group_label>Acetaminophen along with a reduced quantity of Percocet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Percocet only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>acetaminophen 600 mg to be taken every 8 hours (TID)</description>
    <arm_group_label>Acetaminophen along with a reduced quantity of Percocet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Percocet</intervention_name>
    <description>Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
    <arm_group_label>Acetaminophen along with a reduced quantity of Percocet</arm_group_label>
    <arm_group_label>Percocet only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA class I-II&#xD;
&#xD;
          -  Patients indicated and scheduled for arthroscopic hip surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication to acetaminophen or oxycodone/acetaminophen (e.g. hypersensitivity,&#xD;
             history of GI or bleeding disorder)&#xD;
&#xD;
          -  Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia,&#xD;
             etc.)&#xD;
&#xD;
          -  Younger than 18 years of age or older than 65&#xD;
&#xD;
          -  Any patient considered a vulnerable subject&#xD;
&#xD;
          -  Patients on pain medication prior to surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Youm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>April 18, 2018</study_first_submitted>
  <study_first_submitted_qc>April 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2018</study_first_posted>
  <results_first_submitted>December 11, 2020</results_first_submitted>
  <results_first_submitted_qc>December 11, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 7, 2021</results_first_posted>
  <last_update_submitted>December 11, 2020</last_update_submitted>
  <last_update_submitted_qc>December 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 15, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/10/NCT03510910/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Acetaminophen Along With a Reduced Quantity of Percocet</title>
          <description>Acetaminophen: acetaminophen 600 mg to be taken every 8 hours (TID)&#xD;
Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
        </group>
        <group group_id="P2">
          <title>Percocet Only</title>
          <description>Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Incomplete Survey</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Acetaminophen Along With a Reduced Quantity of Percocet</title>
          <description>Acetaminophen: acetaminophen 600 mg to be taken every 8 hours (TID)&#xD;
Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
        </group>
        <group group_id="B2">
          <title>Percocet Only</title>
          <description>Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="40"/>
            <count group_id="B2" value="40"/>
            <count group_id="B3" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="40"/>
                    <count group_id="B2" value="40"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39.43" spread="13.1"/>
                    <measurement group_id="B2" value="40.2" spread="16.5"/>
                    <measurement group_id="B3" value="39.82" spread="14.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="40"/>
                    <count group_id="B2" value="40"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="40"/>
                    <count group_id="B2" value="40"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Patient Satisfaction</title>
        <description>Satisfaction was reported on a Likert-type scale of 1-10 (the higher the score, the higher the satisfaction)</description>
        <time_frame>7 days post-surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen Along With a Reduced Quantity of Percocet</title>
            <description>Acetaminophen: acetaminophen 600 mg to be taken every 8 hours (TID)&#xD;
Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
          </group>
          <group group_id="O2">
            <title>Percocet Only</title>
            <description>Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction</title>
          <description>Satisfaction was reported on a Likert-type scale of 1-10 (the higher the score, the higher the satisfaction)</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.48" spread="1.52"/>
                    <measurement group_id="O2" value="8.83" spread="1.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Morphine-equivalent Consumption</title>
        <description>Amount of oxycodone/acetaminophen (Percocet) in 5mg/325mg doses will be recorded in number of pills</description>
        <time_frame>7 days post-surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen Along With a Reduced Quantity of Percocet</title>
            <description>Acetaminophen: acetaminophen 600 mg to be taken every 8 hours (TID)&#xD;
Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
          </group>
          <group group_id="O2">
            <title>Percocet Only</title>
            <description>Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
          </group>
        </group_list>
        <measure>
          <title>Morphine-equivalent Consumption</title>
          <description>Amount of oxycodone/acetaminophen (Percocet) in 5mg/325mg doses will be recorded in number of pills</description>
          <units>pills</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.33" spread="7.1"/>
                    <measurement group_id="O2" value="5.69" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Score on Visual Analog Scale (VAS) of Pain</title>
        <description>Pain severity scores at rest will be assessed by use of VAS. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain.&quot; The higher the score, the worse the pain.</description>
        <time_frame>24 hours post-surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen Along With a Reduced Quantity of Percocet</title>
            <description>Acetaminophen: acetaminophen 600 mg to be taken every 8 hours (TID)&#xD;
Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
          </group>
          <group group_id="O2">
            <title>Percocet Only</title>
            <description>Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
          </group>
        </group_list>
        <measure>
          <title>Score on Visual Analog Scale (VAS) of Pain</title>
          <description>Pain severity scores at rest will be assessed by use of VAS. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain.&quot; The higher the score, the worse the pain.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.30" spread="2.02"/>
                    <measurement group_id="O2" value="4.98" spread="2.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Score on Visual Analog Scale (VAS) of Pain</title>
        <description>Pain severity scores at rest will be assessed by use of VAS. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain.&quot; The higher the score, the worse the pain.</description>
        <time_frame>4 days post-surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen Along With a Reduced Quantity of Percocet</title>
            <description>Acetaminophen: acetaminophen 600 mg to be taken every 8 hours (TID)&#xD;
Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
          </group>
          <group group_id="O2">
            <title>Percocet Only</title>
            <description>Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
          </group>
        </group_list>
        <measure>
          <title>Score on Visual Analog Scale (VAS) of Pain</title>
          <description>Pain severity scores at rest will be assessed by use of VAS. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain.&quot; The higher the score, the worse the pain.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.55" spread="1.68"/>
                    <measurement group_id="O2" value="3.20" spread="1.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Score on Visual Analog Scale (VAS) of Pain</title>
        <description>Pain severity scores at rest will be assessed by use of VAS. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain.&quot; The higher the score, the worse the pain.</description>
        <time_frame>7 days post-surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen Along With a Reduced Quantity of Percocet</title>
            <description>Acetaminophen: acetaminophen 600 mg to be taken every 8 hours (TID)&#xD;
Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
          </group>
          <group group_id="O2">
            <title>Percocet Only</title>
            <description>Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
          </group>
        </group_list>
        <measure>
          <title>Score on Visual Analog Scale (VAS) of Pain</title>
          <description>Pain severity scores at rest will be assessed by use of VAS. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain.&quot; The higher the score, the worse the pain.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.20" spread="1.79"/>
                    <measurement group_id="O2" value="2.83" spread="2.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Acetaminophen Along With a Reduced Quantity of Percocet</title>
          <description>Acetaminophen: acetaminophen 600 mg to be taken every 8 hours (TID)&#xD;
Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
        </group>
        <group group_id="E2">
          <title>Percocet Only</title>
          <description>Percocet: Oxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group.&#xD;
Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Thomas Youm, MD</name_or_title>
      <organization>NYU Langone Health</organization>
      <phone>212-348-3636</phone>
      <email>Thomas.Youm@nyulangone.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

